Low-dose ethanol consumption inhibits neutrophil extracellular traps formation to alleviate rheumatoid arthritis

被引:0
|
作者
Lin Jin
Ziwei Zhang
Pin Pan
Yuchen Zhao
Mengqi Zhou
Lianghu Liu
Yuanfang Zhai
Han Wang
Li Xu
Dan Mei
Han Zhang
Yining Yang
Jinghan Hua
Xianzheng Zhang
Lingling Zhang
机构
[1] Anhui Medical University,Institute of Clinical Pharmacology
[2] Key Laboratory of Anti-inflammatory and Immune Medicine,Department of orthopedics, The Second People’s Hospital of Hefei
[3] Ministry of Education,undefined
[4] Anti-inflammatory Immune Drugs Collaborative Innovation Center,undefined
[5] Hefei Hospital Affiliated to Anhui Medical University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease. Ethanol consumption has been reported to reduce morbidity in RA patients, but the mechanism behind it remains unclear. Our results showed that Muribaculaceae was predominant in the gut microbiota of mice after ethanol treatment, and the levels of microbiota metabolite acetate were increased. Acetate reduced arthritis severity in collagen-induced arthritis (CIA) mice, which was associated with a decrease in the articular neutrophils and the myeloperoxidase-deoxyribonucleic acid complex in serum. Meanwhile, in vitro experiments confirmed that acetate affected neutrophil activity by acting on G-protein-coupled receptor 43, which reduced endoplasmic reticulum stress in neutrophils and inhibited neutrophil extracellular traps formation. Furthermore, exogenous acetate reversed CIA mice with exacerbated gut microbial disruption, further confirming that the effect of gut microbial metabolite acetate on neutrophils in vivo is crucial for the immune regulation. Our findings illuminate the metabolic and cellular mechanisms of the gut-joint axis in the regulation of autoimmune arthritis, and may offer alternative avenues to replicate or induce the joint-protective benefits of ethanol without associated detrimental effects.
引用
收藏
相关论文
共 50 条
  • [41] Low-dose methotrexate: A mainstay in the treatment of rheumatoid arthritis
    Cronstein, BN
    PHARMACOLOGICAL REVIEWS, 2005, 57 (02) : 163 - 172
  • [42] LOW-DOSE METHOTREXATE TREATMENT OF RHEUMATOID-ARTHRITIS
    PUCHNER, R
    STEGLEGGERFRIEDE, B
    ROITHINGER, FX
    KNOFLACH, P
    ACTA MEDICA AUSTRIACA, 1994, 21 (04) : 107 - 110
  • [43] LOW-DOSE GLUCOCORTICOID THERAPY IN RHEUMATOID-ARTHRITIS
    TREVES, R
    REVUE DU RHUMATISME, 1995, 62 (10): : 611 - 617
  • [44] LOW-DOSE ORAL METHOTREXATE IN RHEUMATOID-ARTHRITIS
    CHAMOT, AM
    GERSTER, JC
    VANMELLE, G
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1988, 118 (36) : 1267 - 1271
  • [45] EFFICACY OF LOW-DOSE METHOTREXATE IN RHEUMATOID-ARTHRITIS
    WEINBLATT, ME
    COBLYN, JS
    FOX, DA
    FRASER, PA
    HOLDSWORTH, DE
    GLASS, DN
    TRENTHAM, DE
    NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (13): : 818 - 822
  • [46] Add-on low-dose prednisolone in rheumatoid arthritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2022, 4 (07): : E466 - E466
  • [47] The use of low-dose prednisone in the management of rheumatoid arthritis
    Lim, SS
    Conn, DL
    BULLETIN ON THE RHEUMATIC DISEASES, 2001, 50 (12) : 1 - 4
  • [48] Systemic low-dose glucocorticoid treatment in rheumatoid arthritis
    Kirwan, JR
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2001, 27 (02) : 389 - 403
  • [49] Desmopressin and low-dose ACTH test in rheumatoid arthritis
    Foppiani, L
    Cutolo, M
    Sessarego, P
    Sulli, A
    Prete, C
    Seriolo, B
    Giusti, M
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1998, 138 (03) : 294 - 301
  • [50] LOW-DOSE PREDNISOLONE THERAPY IN RHEUMATOID-ARTHRITIS
    BAUMANN, M
    ZEIDLER, H
    RAU, R
    STROEHMANN, I
    WARNATZ, H
    AKTUELLE RHEUMATOLOGIE, 1993, 18 (02) : 62 - 68